Huaguan Biotech

Huaguan Biotech

桦冠生物

Huaguan Biotech

Biotech/Healthcare

Huaguan Biotechnology was founded in 2018. It is developing several core technology platforms, including continuous-flow and enzymatic biosynthesis technologies for the green and safe production of active pharmaceutical ingredients, as well as a globally leading “one-arrow-multiple-satellites” ADC…

Latest round: Series C (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-02-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.